OMEGA PHARMA INVEST NV

OMEGA PHARMA INVEST NV is a Naamloze vennootschap in NAZARETH, Belgium that reports a consolidating parent, so its accounts form part of a larger group.

The LEI has been on record for 9 years, since 15 Jun 2017. That is about 4 years earlier than the median LEI in Belgium, which dates from 2020 — an early adopter by local standards.

Annual re-validation is 3031 days overdue: it fell due 13 Jun 2018. An LEI that is not re-validated lapses, which does not invalidate it but marks the reference data as unverified.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The entity is registered with Crossroad Bank of Enterprises under registry number 0439.658.834, and the LEI itself is issued and maintained by LONDON STOCK EXCHANGE LEI LIMITED, one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 1 ISIN is mapped to this entity in the GLEIF cross-reference files.

Its ultimate accounting-consolidating parent — the highest entity in the chain that consolidates it into published accounts — is PERRIGO COMPANY PUBLIC LIMITED COMPANY, which is also its direct parent, so the consolidation chain is one level deep.

The LEI registration is lapsed, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.